Hi-Risk/Recurrent/Advanced PCa Video Chat, Apr 12, 2022

by | Apr 15, 2022 | Prostate Cancer, Recorded Groups

Intermediate Risk Prostate Cancer Graphic

Hi-Risk/Recurrent/Advanced PCa Video Chat, Apr 12, 2022

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about this and our other 10 monthly prostate cancer groups at https://ancan.org/prostate-cancer/       Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Editor’s Pick: We are talking lots of appetite, diet and exercise to manage ADT & chemo this week (rd)

Topics Discussed

Appetite issues; enz and dizzy spells; ARASENS darolutamide trial; hot flashes … again; creeping up on darolutamide ; PSA testing – to how many decimal places?; 2 men consider mitigating ADT with exercise and more; not all PCa in same man makes PSMA; Pluvicto continues to bring PSA down

Chat Log

Marc Valens (to Everyone): 3:23 PM: Try Larabars. No added sugar, just fruit and nuts

AnCan Herb (to Everyone): 3:38 PM: Enzalutamide can cause hypertension, but no information on postural hypotension

Len Sierra (to Organizer(s) Only): 3:40 PM: From RxList website: Stop using enzalutamide and call your doctor at once if you have: dizziness, spinning sensation; a seizure (black-out or convulsions);

AnCan – rick (to Organizer(s) Only): 3:43 PM: Len – that’s the concern around it causing seizure

AnCan – rick (to Everyone): 3:44 PM: ARANOTE and ARASEC

ARANOTE (Saad) …… https://www.urotoday.com/video-lectures/clinical-trials-for-my-patients-prostate-cancer/video/mediaitem/2533-aranote-darolutamide-in-addition-to-adt-vs-adt-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-fred-saad.html?utm_source=newsletter_10261&utm_medium=email&utm_campaign=clinical-trials-for-my-patients-in-prostate-cancer&acm=30276_10261

ARASEC (Shore) Aranote ….https://www.urotoday.com/video-lectures/clinical-trials-for-my-patients-prostate-cancer/video/mediaitem/2548-darolutamide-plus-adt-in-metastatic-hormone-sensitive-prostate-cancer-the-arasec-trial-neal-shore.html?utm_source=newsletter_10261&utm_medium=email&utm_campaign=clinical-trials-for-my-patients-in-prostate-cancer&acm=30276_10261

James Barnes (to Everyone): 4:43 PM: I also was on Enzalutimide and could not tolerate the anxiety and brain fog. I have been doing much better on Aberaterone for the past 6 months.

Frank Fabish – Ohio (to Everyone): 4:45 PM: Hey guys got to go. Thanks for your input. See you next Monday.

Jim Ward (to Everyone): 5:08 PM: Gotta run, gents. Good night!

Len Sierra (to Organizer(s) Only): 5:12 PM: G’night, Gents.

Peter Monaco (to Organizer(s) Only): 5:17 PM: Good evening gents!

John Birch (to Everyone): 5:17 PM: Great news on the numbers Dennis! Need to go, thanks everyone!

AnCan Herb (to Everyone): 5:18 PM: I gotta go. For those celebrating Passover, I hope you enjoy your Seder. And then for those celebrating Easter, all the best.